SGH
Click for more information
0.00% 54.5¢ slater & gordon limited

29 February, page-3

  1. radiant321
    1,799 Posts.
    lightbulb Created with Sketch. 7
    clock Created with Sketch.
    12/02/16
    21:01
    Post #: 17009363
    The HY will certainly contain record revenues and record EBITDA before any non cash write down

    The only question is cash flow which is largely dependant on NIHL settlements
    SGH Price at posting: 61.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03
right-arrow Created with Sketch.
NEWS Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial
right-arrow Created with Sketch.
NEWS Positive diamond results allow for scoping study update
right-arrow Created with Sketch.
NEWS FDA clearance secured for AI-enabled EchoSolv AS – ready for rapid U.S. market launch
right-arrow Created with Sketch.
NEWS Waroona Project financing strategy aims for non-dilutive funding solutions - discover how this approach will support its Stage One development
right-arrow Created with Sketch.
NEWS See what company has secured $98M, 8-year contract renewal with Mercy Health
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SGH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.